Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A New Agent GM-CT-01 in Combination With 5-FU, Avastin and Leucovorin in Subjects With Colorectal Cancer

This study has been terminated.
(Financing and re-organization)
Sponsor:
Information provided by (Responsible Party):
Galectin Therapeutics Inc.
ClinicalTrials.gov Identifier:
NCT00388700
First received: October 13, 2006
Last updated: August 8, 2016
Last verified: August 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2009
  Primary Completion Date: June 2009 (Final data collection date for primary outcome measure)